CLOV.NASDAQClover Health Investments, CORP /DE

Form 4: Clover Health CEO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report 4 August 2025 5:31 PM

📋All filings for Clover Health Investments, CORP /DE

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, disposed of 29,513 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Summary

Jamie L. Reynoso, CEO, Medicare Advantage of Clover Health Investments, Corp. (CLOV), reported a transaction.
On July 31, 2025, 29,513 shares of Class A Common Stock were disposed of.
These shares were withheld at a price of $2.89 per share to cover tax obligations.
The disposition was due to the vesting of 12.5% of time-based restricted stock units (RSUs) originally granted on October 31, 2023.
Following this transaction, Jamie L. Reynoso beneficially owns 3,268,308 shares of Class A Common Stock.
The remaining RSUs are scheduled for final vesting on October 31, 2025, contingent on continued service.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding event related to RSU vesting, which is a standard part of executive compensation and does not indicate a change in company fundamentals or insider sentiment beyond the pre-scheduled vesting.

Positives

Vesting of restricted stock units (RSUs) for the CEO, indicating compensation realization.

Negatives

Disposition of 29,513 shares of Class A Common Stock, reducing direct beneficial ownership.

Future Outlook

Remaining restricted stock units (RSUs) are scheduled for final vesting on October 31, 2025, contingent on the reporting person's continued service.

Industry Context

Stakeholder Impact

Shareholders: The transaction is a routine compensation event and does not indicate a significant shift in company strategy or financial health. It represents a minor reduction in direct insider ownership due to tax obligations.

Next Steps

Final vesting of remaining restricted stock units (RSUs) for the reporting person is scheduled for October 31, 2025, subject to continued service.

Key Dates

Date	Description
10/31/2023	Date original time-based restricted stock units (RSUs) were granted to the Reporting Person.
07/31/2025	Date of transaction, representing the vesting of 12.5% of original RSUs and subsequent share disposition for tax obligations.
08/04/2025	Date the Form 4 was signed and filed.
10/31/2025	Final vesting date for the remaining restricted stock units (RSUs), subject to continued service.

Recommendation

hold

This Form 4 filing details a routine insider transaction where shares were disposed of to cover tax obligations upon RSU vesting. It does not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The transaction is a standard compensation event and does not reflect a discretionary sale or purchase based on new insights into the company's prospects. Therefore, a 'hold' recommendation is maintained, pending further fundamental analysis of Clover Health's business.

Keywords

Clover Health, CLOV, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Jamie L. Reynoso, Medicare Advantage

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.